Michael J. Buckley
No más puestos en curso
Origen de la red de primer grado Michael J. Buckley.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
24
| Subsidiary | Biotechnology | 24 |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Extinct | Biotechnology | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michael J. Buckley a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| HUMANIGEN, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman President Director of Finance/CFO | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Biotechnology | Director/Board Member Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| AFFYMAX, INC. | Biotechnology | Chief Executive Officer Investor Relations Contact | |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
| Seattle University | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member General Counsel General Counsel | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| PHASERX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Founder Investor Relations Contact Corporate Officer/Principal | |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Biotechnology | Director/Board Member Director/Board Member | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Chairman | |
| ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member President | |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 48 |
| Canadá | 3 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 40 |
| Consumer Services | 9 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 188 |
| Corporate Officer/Principal | 123 |
| Chief Tech/Sci/R&D Officer | 52 |
| Independent Dir/Board Member | 48 |
| Chairman | 43 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Ron Hunt | 29 |
| Arlene Morris | 28 |
| Samuel Saks | 28 |
| Michael Bigham | 27 |
| George Tidmarsh | 22 |
| Michelle Griffin | 18 |
| Gregory Overholtzer | 17 |
| Ronald L. Goode | 16 |
| Robert Hershberg | 16 |
| Robert Copeland | 15 |
| Steven Reed | 15 |
| Sylvia R. Wheeler | 14 |
| Mark P. Backer | 14 |
| Eric Bell | 13 |
- Bolsa de valores
- Insiders
- Michael J. Buckley
- Conexiones Empresas